全文获取类型
收费全文 | 358791篇 |
免费 | 33236篇 |
国内免费 | 25979篇 |
专业分类
耳鼻咽喉 | 3135篇 |
儿科学 | 3747篇 |
妇产科学 | 3659篇 |
基础医学 | 41420篇 |
口腔科学 | 6020篇 |
临床医学 | 48043篇 |
内科学 | 51261篇 |
皮肤病学 | 3653篇 |
神经病学 | 19353篇 |
特种医学 | 13774篇 |
外国民族医学 | 217篇 |
外科学 | 36345篇 |
综合类 | 63500篇 |
现状与发展 | 95篇 |
一般理论 | 36篇 |
预防医学 | 23916篇 |
眼科学 | 9838篇 |
药学 | 38089篇 |
393篇 | |
中国医学 | 21356篇 |
肿瘤学 | 30156篇 |
出版年
2024年 | 895篇 |
2023年 | 4704篇 |
2022年 | 11559篇 |
2021年 | 17634篇 |
2020年 | 13313篇 |
2019年 | 11431篇 |
2018年 | 12073篇 |
2017年 | 11197篇 |
2016年 | 10710篇 |
2015年 | 16265篇 |
2014年 | 20184篇 |
2013年 | 18257篇 |
2012年 | 27241篇 |
2011年 | 30632篇 |
2010年 | 20325篇 |
2009年 | 16370篇 |
2008年 | 20483篇 |
2007年 | 20581篇 |
2006年 | 20006篇 |
2005年 | 19532篇 |
2004年 | 12555篇 |
2003年 | 11691篇 |
2002年 | 9861篇 |
2001年 | 7836篇 |
2000年 | 8045篇 |
1999年 | 8160篇 |
1998年 | 5331篇 |
1997年 | 5361篇 |
1996年 | 4081篇 |
1995年 | 3885篇 |
1994年 | 3216篇 |
1993年 | 2167篇 |
1992年 | 2391篇 |
1991年 | 1998篇 |
1990年 | 1678篇 |
1989年 | 1427篇 |
1988年 | 1207篇 |
1987年 | 1015篇 |
1986年 | 804篇 |
1985年 | 646篇 |
1984年 | 394篇 |
1983年 | 239篇 |
1982年 | 141篇 |
1981年 | 144篇 |
1980年 | 102篇 |
1979年 | 101篇 |
1978年 | 19篇 |
1975年 | 16篇 |
1973年 | 16篇 |
1972年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献52.
Jinju Wang Shuzhen Chen Wenfeng Zhang Yanfang Chen Ji C. Bihl 《CNS Neuroscience & Therapeutics》2020,26(12):1255
AimsWe previously showed that the protective effects of endothelial progenitor cells (EPCs)‐released exosomes (EPC‐EXs) on endothelium in diabetes. However, whether EPC‐EXs are protective in diabetic ischemic stroke is unknown. Here, we investigated the effects of EPC‐EXs on diabetic stroke mice and tested whether miR‐126 enriched EPC‐EXs (EPC‐EXsmiR126) have enhanced efficacy.MethodsThe db/db mice subjected to ischemic stroke were intravenously administrated with EPC‐EXs 2 hours after ischemic stroke. The infarct volume, cerebral microvascular density (MVD), cerebral blood flow (CBF), neurological function, angiogenesis and neurogenesis, and levels of cleaved caspase‐3, miR‐126, and VEGFR2 were measured on day 2 and 14.ResultsWe found that (a) injected EPC‐EXs merged with brain endothelial cells, neurons, astrocytes, and microglia in the peri‐infarct area; (b) EPC‐EXsmiR126 were more effective than EPC‐EXs in decreasing infarct size and increasing CBF and MVD, and in promoting angiogenesis and neurogenesis as well as neurological functional recovery; (c) These effects were accompanied with downregulated cleaved caspase‐3 on day 2 and vascular endothelial growth factor receptor 2 (VEGFR2) upregulation till day 14.ConclusionOur results indicate that enrichment of miR126 enhanced the therapeutic efficacy of EPC‐EXs on diabetic ischemic stroke by attenuating acute injury and promoting neurological function recovery. 相似文献
53.
54.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
55.
56.
57.
Peng Li Sha-Sha Tao Meng-Qin Zhao Jun Li Xiu Wang Hai-Feng Pan 《Immunological investigations》2015,44(7):603-615
Objective: Association of matrix metalloproteinases (MMPs) gene polymorphisms with rheumatoid arthritis is controversial. We conduct a meta-analysis to clarify this dispute.Methods: We systematically searched the electronic PUBMED, EMBASE and CNKI databases for research articles about MMPs (MMP-1, MMP-2, MMP-3, MMP-9) gene polymorphisms and rheumatoid arthritis (RA) up to January 2015. According to the heterogeneity, fixed-effects or random-effects models were used to calculate crude odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: A total of 11 articles involving 2143 cases and 2049 controls were included in this meta-analysis. Overall, no significant associations were observed between MMP-1-1607 1G/2G polymorphism and RA. Stratification by ethnicity, no significant associations were observed in Caucasian populations. Similarly, no significant associations were observed between MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms and RA in overall and Caucasian populations, respectively. However, a weak association was found between MMP-2-1306 C/T polymorphism and RA (C vs. T, OR?=?0.813, 95%CI?=?0.694–0.953, p?=?0.010) in overall populations.Conclusions: The present meta-analysis suggests that MMP-1-1607 1G/2G, MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms are not associated with the susceptibility of RA, but MMP-2 -1306 C/T is weakly associated with susceptibility to RA. Further studies with more sample size are needed for definitive conclusions. 相似文献
58.
European Archives of Oto-Rhino-Laryngology - Several polymorphisms in a disintegrin and metalloproteinase 33 (ADAM33) have been implicated in susceptibility to allergic rhinitis (AR), but the... 相似文献
59.
60.
我国属胃癌高发国家,且以进展期胃癌为主。以手术和化疗为主的多学科治疗无法有效改善晚期胃癌患者的预后。近年来,免疫检查点抑制剂类药物的疗效在诸多癌症中得到了证实,因此,该类药物在胃癌中的治疗效果也受到了广泛的关注。本文对近年来的相关研究成果进行综述,全面介绍了免疫检查点抑制剂类药物在胃癌治疗中的临床应用情况、联合用药情况以及不良反应。对于其他治疗均失败的晚期胃癌患者,PD-1抑制剂是一个可行的治疗选项,其代表药物派姆单抗是目前唯一被美国食品药品监督管理局批准应用于胃癌治疗的免疫抑制剂类药物,而我国国家食品药品监督管理总局尚未批准任何此类药物应用于胃癌的临床治疗。如何进一步提高治疗的客观缓解率,将会是后续临床和基础研究的一大焦点。 相似文献